FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300688538> ?p ?o ?g. }

• W4300688538 endingPage "107602962211212" @default.
• W4300688538 startingPage "107602962211212" @default.
• W4300688538 abstract "ObjectsTo investigate the potential clinical significance between blood lipid levels and lower extremity deep venous thrombosis (LEDVT). Methods: This cohort study included 500 participants, contains 246 patients with LEDVT and 254 patients without LEDVT. The characteristics including age, sex, body mass index (BMI), disease course, ill position, smoking history, history of current illness, drug administration were collected. And blood lipid levels and other clinical parameters including triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), activated partial thromboplastin time (APTT), thromboplastin time (TT), prothrombin time (PT), and fibrinogen (FIB), neutrophils (NEUT), platelet (PLT), lymphocyte count (LY) were observed. Univariate and multivariate logistic regression analyses were applied. In the present study we particularly focused on the potential associations between blood lipid levels and LEDVT. Results: The risk of LEDVT in participants with HDL-C levels of 0.965 to 1.14 mmol/L, 1.14 to 1.36 mmol/L, and >1.36 mmol/L were 0.366, 0.183, 0.203 times than in controls (<0.965 mmol/L), respectively. Compared to individuals with ApoA1 <1.06 mmol/L, individuals with ApoA1 levels of 1.06 to 1.22 mmol/L, 1.22 to 1.38 mmol/L, and >1.38 mmol/L were related to a decreased risk of LEDVT. The risk of LEDVT in patients with TG levels of 0.985 to 1.37 mmol/L, 1.37 to 1.91 mmol/L, and >1.91 mmol/L were 2.243, 2.224, and 2.540 times higher than that of those with TG <0.985 mmol/L, respectively. The risk of LEDVT in subjects with 4.57< TC <5.17 mmol/L was 0.471-fold than that of those with TC <3.97 mmol/L. Conclusion: The present study indicates that higher levesl of HDL-C and ApoA1 could be associated with a decreased risk of LEDVT, while higher TG levels might be associated with an increased risk of LEDVT. In addition, within the normal range, high TC levels were associated with decreased risk of LEDVT. These findings may help clinicals to identify early and treat those patients with a high-risk of LEDVT at proper time, which could improve patients' life quality." @default.
• W4300688538 created "2022-10-04" @default.
• W4300688538 creator A5006822602 @default.
• W4300688538 creator A5054399541 @default.
• W4300688538 creator A5063637294 @default.
• W4300688538 creator A5082213642 @default.
• W4300688538 date "2022-01-01" @default.
• W4300688538 modified "2023-10-12" @default.
• W4300688538 title "Association Between Blood Lipid Levels and Lower Extremity Deep Venous Thrombosis: A Population-Based Cohort Study" @default.
• W4300688538 cites W1681995079 @default.
• W4300688538 cites W1928910362 @default.
• W4300688538 cites W1967600226 @default.
• W4300688538 cites W1977483112 @default.
• W4300688538 cites W2006666326 @default.
• W4300688538 cites W2025413651 @default.
• W4300688538 cites W2035010389 @default.
• W4300688538 cites W2052886863 @default.
• W4300688538 cites W2060250894 @default.
• W4300688538 cites W2077420019 @default.
• W4300688538 cites W2078628617 @default.
• W4300688538 cites W2082351543 @default.
• W4300688538 cites W2087782461 @default.
• W4300688538 cites W2093104471 @default.
• W4300688538 cites W2109669564 @default.
• W4300688538 cites W2133454964 @default.
• W4300688538 cites W2143290702 @default.
• W4300688538 cites W2168489556 @default.
• W4300688538 cites W2294236942 @default.
• W4300688538 cites W2397345552 @default.
• W4300688538 cites W2539477305 @default.
• W4300688538 cites W2568859237 @default.
• W4300688538 cites W2589055252 @default.
• W4300688538 cites W2618671205 @default.
• W4300688538 cites W2774613779 @default.
• W4300688538 cites W2782406355 @default.
• W4300688538 cites W2790131754 @default.
• W4300688538 cites W2794153191 @default.
• W4300688538 cites W2885720444 @default.
• W4300688538 cites W3080719532 @default.
• W4300688538 cites W3108117255 @default.
• W4300688538 cites W4210745803 @default.
• W4300688538 cites W872044831 @default.
• W4300688538 doi "https://doi.org/10.1177/10760296221121282" @default.
• W4300688538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36189865" @default.
• W4300688538 hasPublicationYear "2022" @default.
• W4300688538 type Work @default.
• W4300688538 citedByCount "1" @default.
• W4300688538 countsByYear W43006885382023 @default.
• W4300688538 crossrefType "journal-article" @default.
• W4300688538 hasAuthorship W4300688538A5006822602 @default.
• W4300688538 hasAuthorship W4300688538A5054399541 @default.
• W4300688538 hasAuthorship W4300688538A5063637294 @default.
• W4300688538 hasAuthorship W4300688538A5082213642 @default.
• W4300688538 hasBestOaLocation W43006885381 @default.
• W4300688538 hasConcept C126322002 @default.
• W4300688538 hasConcept C134018914 @default.
• W4300688538 hasConcept C144301174 @default.
• W4300688538 hasConcept C2778163477 @default.
• W4300688538 hasConcept C2778261982 @default.
• W4300688538 hasConcept C2778382381 @default.
• W4300688538 hasConcept C2779036427 @default.
• W4300688538 hasConcept C2780011451 @default.
• W4300688538 hasConcept C2780221984 @default.
• W4300688538 hasConcept C2780434524 @default.
• W4300688538 hasConcept C2780745583 @default.
• W4300688538 hasConcept C2780868729 @default.
• W4300688538 hasConcept C38180746 @default.
• W4300688538 hasConcept C62746215 @default.
• W4300688538 hasConcept C71924100 @default.
• W4300688538 hasConcept C72563966 @default.
• W4300688538 hasConcept C90924648 @default.
• W4300688538 hasConceptScore W4300688538C126322002 @default.
• W4300688538 hasConceptScore W4300688538C134018914 @default.
• W4300688538 hasConceptScore W4300688538C144301174 @default.
• W4300688538 hasConceptScore W4300688538C2778163477 @default.
• W4300688538 hasConceptScore W4300688538C2778261982 @default.
• W4300688538 hasConceptScore W4300688538C2778382381 @default.
• W4300688538 hasConceptScore W4300688538C2779036427 @default.
• W4300688538 hasConceptScore W4300688538C2780011451 @default.
• W4300688538 hasConceptScore W4300688538C2780221984 @default.
• W4300688538 hasConceptScore W4300688538C2780434524 @default.
• W4300688538 hasConceptScore W4300688538C2780745583 @default.
• W4300688538 hasConceptScore W4300688538C2780868729 @default.
• W4300688538 hasConceptScore W4300688538C38180746 @default.
• W4300688538 hasConceptScore W4300688538C62746215 @default.
• W4300688538 hasConceptScore W4300688538C71924100 @default.
• W4300688538 hasConceptScore W4300688538C72563966 @default.
• W4300688538 hasConceptScore W4300688538C90924648 @default.
• W4300688538 hasLocation W43006885381 @default.
• W4300688538 hasLocation W43006885382 @default.
• W4300688538 hasLocation W43006885383 @default.
• W4300688538 hasLocation W43006885384 @default.
• W4300688538 hasOpenAccess W4300688538 @default.
• W4300688538 hasPrimaryLocation W43006885381 @default.
• W4300688538 hasRelatedWork W1857288271 @default.
• W4300688538 hasRelatedWork W1972266366 @default.
• W4300688538 hasRelatedWork W2029341269 @default.
• W4300688538 hasRelatedWork W2035952571 @default.

• next